• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国T1期乳腺癌患者区域淋巴结转移的临床病理危险因素识别:一项基于人群的研究。

Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study.

作者信息

Liu Gang, Xing Zeyu, Guo Changyuan, Dai Qichen, Cheng Han, Wang Xiang, Tang Yu, Wang Yipeng

机构信息

Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Front Oncol. 2023 Aug 4;13:1217869. doi: 10.3389/fonc.2023.1217869. eCollection 2023.

DOI:10.3389/fonc.2023.1217869
PMID:37601676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10436470/
Abstract

OBJECTIVES

To analyze clinicopathological risk factors and regular pattern of regional lymph node metastasis (LNM) in Chinese patients with T1 breast cancer and the effect on overall survival (OS) and disease-free survival (DFS).

MATERIALS AND METHODS

Between 1999 and 2020, breast cancer patients meeting inclusion criteria of unilateral, no distant metastatic site, and T1 invasive ductal carcinoma were reviewed. Clinical pathology characteristics were retrieved from medical records. Survival analysis was performed using Kaplan-Meier methods and an adjusted Cox proportional hazards model.

RESULTS

We enrolled 11,407 eligible patients as a discovery cohort to explore risk factors for LNM and 3484 patients with stage T1N0 as a survival analysis cohort to identify the effect of those risk factors on OS and DFS. Compared with patients with N- status, patients with N+ status had a younger age, larger tumor size, higher Ki67 level, higher grade, higher HR+ and HER2+ percentages, and higher luminal B and HER2-positive subtype percentages. Logistic regression indicated that age was a protective factor and tumor size/higher grade/HR+ and HER2+ risk factors for LNM. Compared with limited LNM (N1) patients, extensive LNM (N2/3) patients had larger tumor sizes, higher Ki67 levels, higher grades, higher HR- and HER2+ percentages, and lower luminal A subtype percentages. Logistic regression indicated that HR+ was a protective factor and tumor size/higher grade/HER2+ risk factors for extensive LNM. Kaplan-Meier analysis indicated that grade was a predictor of both OS and DFS; HR was a predictor of OS but not DFS. Multivariate survival analysis using the Cox regression model demonstrated age and Ki67 level to be predictors of OS and grade and HER2 status of DFS in stage T1N0 patients.

CONCLUSION

In T1 breast cancer patients, there were several differences between N- and N+ patients, limited LNM and extensive LNM patients. Besides, HR+ plays a dual role in regional LNM. In patients without LNM, age and Ki67 level are predictors of OS, and grade and HER2 are predictors of DFS.

摘要

目的

分析中国T1期乳腺癌患者的临床病理危险因素及区域淋巴结转移(LNM)的规律模式,以及其对总生存期(OS)和无病生存期(DFS)的影响。

材料与方法

回顾1999年至2020年间符合单侧、无远处转移灶及T1期浸润性导管癌纳入标准的乳腺癌患者。从病历中提取临床病理特征。采用Kaplan-Meier法和校正后的Cox比例风险模型进行生存分析。

结果

我们纳入了11407例符合条件的患者作为发现队列以探索LNM的危险因素,并纳入3484例T1N0期患者作为生存分析队列以确定这些危险因素对OS和DFS的影响。与N-状态患者相比,N+状态患者年龄更小、肿瘤更大、Ki67水平更高、分级更高、HR+和HER2+百分比更高,以及管腔B和HER2阳性亚型百分比更高。逻辑回归表明年龄是LNM的保护因素,而肿瘤大小/更高分级/HR+和HER2+是危险因素。与局限性LNM(N1)患者相比,广泛性LNM(N2/3)患者肿瘤更大、Ki67水平更高、分级更高、HR-和HER2+百分比更高,以及管腔A亚型百分比更低。逻辑回归表明HR+是广泛性LNM的保护因素,而肿瘤大小/更高分级/HER2+是危险因素。Kaplan-Meier分析表明分级是OS和DFS的预测因素;HR是OS的预测因素,但不是DFS的预测因素。使用Cox回归模型的多因素生存分析表明,在T1N0期患者中,年龄和Ki67水平是OS的预测因素,分级和HER2状态是DFS的预测因素。

结论

在T1期乳腺癌患者中,N-和N+患者、局限性LNM和广泛性LNM患者之间存在若干差异。此外,HR+在区域LNM中起双重作用。在无LNM的患者中,年龄和Ki67水平是OS的预测因素,分级和HER2是DFS的预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbd/10436470/37ca97736e75/fonc-13-1217869-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbd/10436470/c0be2bc0effc/fonc-13-1217869-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbd/10436470/6fdad17a5fa6/fonc-13-1217869-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbd/10436470/37ca97736e75/fonc-13-1217869-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbd/10436470/c0be2bc0effc/fonc-13-1217869-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbd/10436470/6fdad17a5fa6/fonc-13-1217869-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbd/10436470/37ca97736e75/fonc-13-1217869-g003.jpg

相似文献

1
Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study.中国T1期乳腺癌患者区域淋巴结转移的临床病理危险因素识别:一项基于人群的研究。
Front Oncol. 2023 Aug 4;13:1217869. doi: 10.3389/fonc.2023.1217869. eCollection 2023.
2
Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.肝内胆管癌准确的淋巴结分期需要充分的淋巴结清扫: 一项基于人群的研究。
Cancer Med. 2023 Apr;12(7):8184-8198. doi: 10.1002/cam4.5620. Epub 2023 Jan 16.
3
Potential roles of lymphovascular space invasion based on tumor characteristics provide important prognostic information in T1 tumors with ER and HER2 positive breast cancer.基于肿瘤特征的脉管侵犯潜能为 ER 和 HER2 阳性乳腺癌 T1 肿瘤提供了重要的预后信息。
Clin Transl Oncol. 2020 Dec;22(12):2275-2285. doi: 10.1007/s12094-020-02369-9. Epub 2020 May 23.
4
TNM classification and the need for revision of pN3a breast cancer.TNM 分期及 pN3a 期乳腺癌修订的必要性。
Eur J Cancer. 2017 Jul;79:23-30. doi: 10.1016/j.ejca.2017.04.002.
5
[Effects of colpotomic approaches on prognosis and recurrence sites of stage Ⅰa2-Ⅱa2 cervical cancer after laparoscopic radical hysterectomy].[阴道切开术式对Ⅰa2-Ⅱa2期宫颈癌腹腔镜根治性子宫切除术后预后及复发部位的影响]
Zhonghua Fu Chan Ke Za Zhi. 2023 Jan 25;58(1):49-59. doi: 10.3760/cma.j.cn112141-20221022-00647.
6
[Analysis of risk factors of axillary lymph node metastasis and prognosis in T1 breast cancer: a large-scale retrospective study based on the SEER database].T1期乳腺癌腋窝淋巴结转移及预后的危险因素分析:基于监测、流行病学和最终结果(SEER)数据库的大规模回顾性研究
Zhonghua Yi Xue Za Zhi. 2021 Jul 20;101(27):2152-2158. doi: 10.3760/cma.j.cn112137-20201218-03392.
7
Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.中国多中心回顾性研究:激素受体阳性、人表皮生长因子受体 2 阴性乳腺癌新辅助化疗后乳腺病理完全缓解和无病生存的真实世界数据。
World J Surg Oncol. 2022 Sep 29;20(1):326. doi: 10.1186/s12957-022-02787-9.
8
Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry.根据监测、流行病学和最终结果(SEER)登记处的数据,乳腺癌亚型作为淋巴结转移的预测指标。
J Breast Cancer. 2015 Jun;18(2):143-8. doi: 10.4048/jbc.2015.18.2.143. Epub 2015 Jun 26.
9
Clinical significance of extranodal extension in sentinel lymph node positive breast cancer.前哨淋巴结阳性乳腺癌中结外侵犯的临床意义。
Sci Rep. 2020 Sep 7;10(1):14684. doi: 10.1038/s41598-020-71594-7.
10
A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer.基于乳腺癌患者临床病理特征分析的淋巴结阳性 Luminal B HER2 阴性亚型乳腺癌肝转移预测列线图
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221132669. doi: 10.1177/15330338221132669.

本文引用的文献

1
Relative Survival With Early-Stage Breast Cancer in Screened and Unscreened Populations.早期乳腺癌在筛查人群和非筛查人群中的相对生存率。
Mayo Clin Proc. 2022 Dec;97(12):2316-2323. doi: 10.1016/j.mayocp.2022.08.006. Epub 2022 Nov 3.
2
Development of the prediction model based on clinical-imaging omics: molecular typing and sentinel lymph node metastasis of breast cancer.基于临床影像组学的预测模型的开发:乳腺癌的分子分型与前哨淋巴结转移
Ann Transl Med. 2022 Jul;10(13):749. doi: 10.21037/atm-22-2844.
3
Risk Factors, Prognostic Factors, and Nomogram for Distant Metastasis in Breast Cancer Patients Without Lymph Node Metastasis.
乳腺癌患者无淋巴结转移远处转移的危险因素、预后因素和列线图。
Front Endocrinol (Lausanne). 2021 Nov 24;12:771226. doi: 10.3389/fendo.2021.771226. eCollection 2021.
4
Predictors of sentinel lymph node metastasis in Chinese women with clinical T1-T2 N0 breast cancer and a normal axillary ultrasound.中国临床T1-T2 N0期乳腺癌且腋窝超声检查正常的女性前哨淋巴结转移的预测因素
Acta Radiol. 2022 Nov;63(11):1463-1468. doi: 10.1177/02841851211054191. Epub 2021 Oct 30.
5
Identifying Clinicopathological Risk Factors of the Regional Lymph Node Metastasis in Patients with T Mucinous Breast Cancer: A Population-Based Study.T 黏液性乳腺癌患者区域淋巴结转移的临床病理危险因素识别:一项基于人群的研究。
J Oncol. 2021 Jul 9;2021:3866907. doi: 10.1155/2021/3866907. eCollection 2021.
6
Associations of Estrogen Receptor, Progesterone Receptor, Human Epidemic Growth Factor Receptor-2 and Ki-67 with Ultrasound Signs and Prognosis of Breast Cancer Patients.雌激素受体、孕激素受体、人表皮生长因子受体-2及Ki-67与乳腺癌患者超声征象及预后的相关性
Cancer Manag Res. 2021 Jun 9;13:4579-4586. doi: 10.2147/CMAR.S276422. eCollection 2021.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Breast Cancer-Specific Mortality in Small-Sized Tumor with Stage IV Breast Cancer: A Population-Based Study.四期乳腺癌中肿瘤体积小患者的乳腺癌特异性死亡率:一项基于人群的研究。
Oncologist. 2021 Feb;26(2):e241-e250. doi: 10.1002/onco.13567. Epub 2020 Nov 3.
9
Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.不同癌症类型中,按种族和民族划分的诊断时癌症分期、治疗和生存差异。
JAMA Netw Open. 2020 Apr 1;3(4):e202950. doi: 10.1001/jamanetworkopen.2020.2950.
10
Predictors of non-sentinel lymph node metastasis in clinical early stage (cT1-2N0) breast cancer patients with 1-2 metastatic sentinel lymph nodes.1-2 枚转移性前哨淋巴结的临床早期(cT1-2N0)乳腺癌患者中,非前哨淋巴结转移的预测因素。
Asian J Surg. 2020 Apr;43(4):538-549. doi: 10.1016/j.asjsur.2019.07.019. Epub 2019 Sep 10.